期刊文献+

2003—2008年儿科临床分离菌的分布变迁及耐药性监测 被引量:10

The changing pattern and antibiotic resistance of clinical bacterial isolates in a pediatric clinic from 2003 to 2008
暂未订购
导出
摘要 目的了解目前儿科临床分离细菌种类分布及对抗菌药物的耐药性变化。方法对2003—2008年北京儿童医院住院患儿所有临床分离菌株进行分析,药敏试验使用纸片扩散法和Phoenix100微生物分析仪检测,按CLSI2008年标准进行。使用WHONET5.4软件进行数据的统计分析。结果临床分离革兰阴性菌比率呈上升趋势,革兰阴性菌以大肠埃希菌、铜绿假单胞菌和肺炎克雷伯菌为主。革兰阳性菌以金葡菌、肺炎链球菌和凝固酶阴性葡萄球菌为主。肺炎链球菌是儿科呼吸系统、中枢神经系统和血流感染的重要病原菌,在呼吸道标本中其分离率最高,肺炎链球菌对青霉素不敏感率82.5%。耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)占CNS79.8%~92.7%;MRSA升至10.6%。肺炎链球菌、葡萄球菌和肠球菌均未发现耐万古霉素的耐药株,但有万古霉素中介的肠球菌检出。革兰阴性菌中,产ESBLs大肠埃希菌菌株占73.9%~80.0%;肺炎克雷伯菌为70.5%~81.5%。不发酵糖菌的铜绿假单胞菌对碳青霉烯类抗生素(亚胺培南、美罗培南)耐药率分别为11.3%和9.2%,鲍曼不动杆菌对两者的耐药率均为3.3%。结论儿科临床分离CNS、肺炎链球菌、肠球菌属、大肠埃希菌和克雷伯菌属的耐药处于较高水平,加强儿科临床分离细菌的监测,对于了解儿科临床分离细菌分布及其耐药性变迁,指导临床合理用药防止耐药菌产生和播散都有重要意义。 Objective To investigate the changing pattern of common bacterial pathogens and their resistance in the pediatric clinic in Beijing Children's Hospital. Methods All the bacterial isolates isolated in our hospital from 2003 to 2008 were ana- lyzed. Antimicrobial susceptibility was determined by disk diffusion method and Phoenix 100 microbiological system. Results were analyzed according to the guidelines of CLSI. Results Gram-negative bacteria became important pathogens of nosocomial infections. E. coli, P. aeruginosa and K. pneumoniae were the leading gram-negative pathogens. S. aureus, S. pneurnoniae and coagulase-negative Staphylococcus (CNS) were common gram-positive pathogens. About 82.5 % of the S. pneumoniae isolates were penicillin non-susceptible (PNSP). The prevalence of methicillin-resistant CNS (MRCNS) ranged from 79.8% to 92.7%. Up to 10.6% of the S. aureus isolates were methicillin-resistant (MRSA). No isolate of S. pneumoniae, S. aureus or Enterococcus was found resistant to vancomycin. The prevalence of extended-spectrum β-lactamase (ESBLs) producing strains ranged from 73.9% to 80.0% in E. coli and 70.5% to 81.5% in K. pneumoniae. The resistance rate of P. aeruginosa to imipenem and meropenem was 34. 2% and 35.8%, respectively. About 3.3% of the A. baumannii isolates were resistant to carbapenems. Conclusions The clinical strains of CNS, S. pneumoniae, Enterococcus, E. coli and K. pneurnoniae isolated from the pediatric clinic have shown high resistance to multiple antibiotics. The surveillance of antimicrobial resistance is very important for rational antimicrobial therapy and effective control of infections in pediatric clinic.
出处 《中国感染与化疗杂志》 CAS 2009年第6期440-445,共6页 Chinese Journal of Infection and Chemotherapy
基金 国家科技部十五攻关项目(2004BA720A09-01)
关键词 微生物 抗菌药物 细菌耐药性监测 microorganism antimicrobial agent sur- veillance of antibiotic resistance
  • 相关文献

参考文献13

二级参考文献52

  • 1姜敏,杨永弘.流感嗜血杆菌对常用抗生素的耐药性及耐药机制[J].国外医学(儿科学分册),2004,31(5):228-230. 被引量:13
  • 2沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 3王辉,陈民钧,倪语星,陈冬梅,孙自庸,陈燕,赵旺胜,邹雄,俞云松,胡志东,黄心宏,徐英春,谢秀丽,褚云卓,王倩,梅亚宁,田彬,张蓓,孔庆莲,于秀娟,潘玉红.2003—2004年中国十家教学医院革兰阴性杆菌的耐药分析[J].中华检验医学杂志,2005,28(12):1295-1303. 被引量:236
  • 4汪复.多重耐药铜绿假单胞菌与鲍曼不动杆菌严重感染的防治策略[J].中国感染与化疗杂志,2007,7(3):230-232. 被引量:139
  • 5Clinical and Laboratory Standards Institute 2008. Performance standards for antimierobial susceptibility testing: eighteenth informational supplement M100-S18[S]. CLSI, 2008.
  • 6Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species[J]. Clin Infect Dis, 2006,43(Suppl 2):S43-S48.
  • 7Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections[J ]. Lancet Infect Dis, 2008,8 (12) : 751-762.
  • 8Gales AC,Jones RN,Sader HS. Global assessment of the antimicrobial activity of polymycin B against 54 731 clinical isolates of Gram-negtive bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004) [J]. Clin Microbiol Infect, 2006,12(4):315- 321.
  • 9Rafailidis PI, Ioannidou EN, Falagas ME. Ampicillin/sulbactam: current status in severe bacterial infections[J]. Drugs, 2007,67(13) : 1829-1849.
  • 10Henwood CJ, Gatward T, Warner M, et al. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936)[J ]. J Antimicrob Chemother, 2002,49(3):479-487.

共引文献660

同被引文献120

引证文献10

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部